KYMERA THERAPEUTICS, INC. Payments of Financing Costs
KYMERA THERAPEUTICS, INC. (KYMR) reported Payments of Financing Costs of $861.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-05
- KYMERA THERAPEUTICS, INC. payments of financing costs for the quarter ending 2026-06-30 was $436.00K, a 14.14% increase year-over-year.
- KYMERA THERAPEUTICS, INC. payments of financing costs for the quarter ending 2026-03-31 was $425.00K, a 53.43% increase year-over-year.
- KYMERA THERAPEUTICS, INC. payments of financing costs for the quarter ending 2025-12-31 was $416.00K, a 41.98% increase year-over-year.
- KYMERA THERAPEUTICS, INC. payments of financing costs for the quarter ending 2025-09-30 was $419.00K, a 34.63% decline year-over-year.
- KYMERA THERAPEUTICS, INC. payments of financing costs for fiscal 2025 was $1.49M, a 5.20% decline from fiscal 2024.
- KYMERA THERAPEUTICS, INC. payments of financing costs for fiscal 2024 was $1.58M, a 1973.68% increase from fiscal 2023.
- KYMERA THERAPEUTICS, INC. payments of financing costs for fiscal 2023 was $76.00K, a 93.27% decline from fiscal 2022.
- KYMERA THERAPEUTICS, INC. payments of financing costs for fiscal 2022 was $1.13M, a 33.10% increase from fiscal 2021.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $436.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $861.00K 10-Q · filed 2026-08-05 | $1.28M derived: sum of 3 quarters · filed 2026-08-05 | $1.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $425.00K 10-Q · filed 2026-04-30 | $841.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.26M derived: sum of 3 quarters · filed 2026-04-30 | $1.64M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $835.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.22M derived: sum of 3 quarters · filed 2026-08-05 | $1.49M 10-K · filed 2026-02-26 |
| 2025-09-30 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $801.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.08M 10-Q · filed 2025-11-04 | $1.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $382.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $659.00K 10-Q · filed 2026-08-05 | $952.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.59M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $277.00K 10-Q · filed 2026-04-30 | $570.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.21M derived: sum of 3 quarters · filed 2026-04-30 | $1.56M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $934.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.29M derived: sum of 3 quarters · filed 2026-02-26 | $1.58M 10-K · filed 2026-02-26 |
| 2024-09-30 | $641.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $993.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.28M 10-Q · filed 2025-11-04 | $358.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $642.00K 10-Q · filed 2025-08-11 | -$283.00K derived: sum of 3 quarters · filed 2026-02-26 | $57.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $290.00K 10-Q · filed 2025-05-09 | -$635.00K derived: sum of 2 quarters · filed 2026-02-26 | -$295.00K derived: sum of 3 quarters · filed 2026-02-26 | $39.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$585.00K derived: sum of 2 quarters · filed 2026-02-26 | -$251.00K derived: sum of 3 quarters · filed 2026-02-26 | $76.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $674.00K derived: sum of 2 quarters · filed 2024-10-31 | $1.00M 10-Q · filed 2024-10-31 | $1.31M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $661.00K 10-Q · filed 2024-08-07 | $966.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.26M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $327.00K 10-Q · filed 2024-05-02 | $632.00K derived: sum of 2 quarters · filed 2025-02-27 | $924.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.19M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $597.00K derived: sum of 2 quarters · filed 2025-02-27 | $866.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.13M 10-K · filed 2025-02-27 |
| 2022-09-30 | $292.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $561.00K derived: sum of 2 quarters · filed 2023-11-02 | $825.00K 10-Q · filed 2023-11-02 | $981.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $533.00K 10-Q · filed 2023-08-03 | $689.00K derived: sum of 3 quarters · filed 2024-02-22 | $1.04M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $264.00K 10-Q · filed 2023-05-04 | $420.00K derived: sum of 2 quarters · filed 2024-02-22 | $772.00K derived: sum of 3 quarters · filed 2024-02-22 | $958.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $508.00K derived: sum of 2 quarters · filed 2024-02-22 | $694.00K derived: sum of 3 quarters · filed 2024-02-22 | $849.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $538.00K derived: sum of 2 quarters · filed 2022-11-03 | $693.00K 10-Q · filed 2022-11-03 | $845.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $341.00K 10-Q · filed 2022-08-09 | $493.00K derived: sum of 3 quarters · filed 2023-02-23 | $602.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $155.00K 10-Q · filed 2022-05-03 | $307.00K derived: sum of 2 quarters · filed 2023-02-23 | $416.00K derived: sum of 3 quarters · filed 2023-02-23 | $567.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $261.00K derived: sum of 2 quarters · filed 2023-02-23 | $412.00K derived: sum of 3 quarters · filed 2023-02-23 | $554.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $260.00K derived: sum of 2 quarters · filed 2021-11-10 | $402.00K 10-Q · filed 2021-11-10 | $520.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $293.00K 10-Q · filed 2021-08-06 | $411.00K derived: sum of 3 quarters · filed 2022-02-24 | |
| 2020-03-31 | $142.00K 10-Q · filed 2021-05-06 | $260.00K derived: sum of 2 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $371.00K 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $253.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |